Cargando…
Comprehensive analysis of common safety profiles and their predictive factors in 520 records of liver cancer patients treated by drug-eluting beads transarterial chemoembolization
This study aimed to investigate the difference of common adverse events (AEs) between patients experienced first drug-eluting beads transarterial chemoembolization (DEB-TACE; FD) and second or higher DEB-TACE (SHD), and the factors influencing AEs. Five hundred twenty DEB-TACE records were retrospec...
Autores principales: | Sun, Junhui, Zhou, Guanhui, Zhang, Yuelin, Zhou, Tanyang, Nie, Chunhui, Zhu, Tongyin, Chen, Shengqun, Wang, Baoquan, Yu, Ziniu, Wang, Hongliang, Chen, Xinhua, Hong, Liangjie, Chen, Liming, Wang, Weilin, Zheng, Shusen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039676/ https://www.ncbi.nlm.nih.gov/pubmed/29952956 http://dx.doi.org/10.1097/MD.0000000000011131 |
Ejemplares similares
-
Analysis of the efficacy of transcatheter arterial infusion chemotherapy in the treatment of pancreatic carcinoma
por: Nie, Chunhui, et al.
Publicado: (2020) -
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015) -
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016) -
Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
por: Zhou, Guan-Hui, et al.
Publicado: (2018)